Aposense is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents based on the identification and targeting of cells undergoing apoptosis (programmed cell death).
Arrayit Corporation empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
Attana AB develops and sells biosensors for analysis of biomolecular interactions. Attana's biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
AuraSense's uniquely engineered nanoparticles possess unparalleled biocompatibility and versatility as therapeutics and as novel assays within live cells. They hold great promise for combating the most threatening diseases, including heart disease, cancer, and bacterial infection.
The company was founded for the purpose of research and development of new therapies for the treatment of specific and hitherto incurable forms of leukaemia. Its business is the production, research and development of targeted pharmaceuticals based on nanoparticle structures.
A specialty pharmaceutical company with a novel drug delivery system. Its proprietary Protein Stabilized Liposomes nanotechnology platform addresses the significant problems associated with delivery of water insoluble drugs.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing – Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.
As a manufacturer of nanoliter dispensing equipment,
BioDot has had extensive experience with the development
BioDot is the leading supplier of system tools for the research, development and commercialization of diagnostic tests. As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development of manufacturing processes for the protein array industry.
Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.
The company is a service partner for all aspects of oligonucleotides. It developed and produced the world's first and only translucent orthodontic systems using novel nanotechnology polymer composite products.
A bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level.